PROSPECTS OF COMBINING INTERLEUKIN-2 WITH IMMUNE CHECKPOINT INHIBITORS FOR CANCER THERAPY. Вопр. онкол. 2020, 66 (1), 23-28. https://doi.org/10.37469/0507-3758-2020-66-1-23-28.